CARDIOVASCULAR JOURNAL OF AFRICA • SMC-PAFCIC Abstracts October 2022 39 AFRICA diagnosed as an unexpected finding during attempts to left-sided venous catheterisation for intracardiac lead placement which can make more challenging and time consuming. Patients with this congenital malformation are at increased risk of developing various cardiac arrhythmias. It affects approximately 0.5 - 2% of individuals with normal heart, and up to 10 % in the presence of an established congenital heart diseases. We present two different challenging cases of persistent left superior vena cava incidentally discovered during device implantation. PLSVC usually comes as a surprise for the cardiologist during cardiac device implantation. Theses case reports emphasize the importance of its knowledge and how to manage it. Although most right heart catheterization procedures can be safely performed in spite of this anomaly transvenous leads implantation can be challenging or even impossible in some cases. Figure 1: Venous angioram showing contrast coursing through the Persistent Left Superior Vena (type IIIb) Figure 2: Chest X-ray showing post-procedure implantation of a dual chamber pacemaker via the right sub-clavian vein. Figure 3: Venography of the left Superior Vena Cava and Coronary Sinus ostium (type IIIA) Figure 4: Chest X-ray showed transveinous leads and left Submission ID: 1547 OUTCOMES AND PROGNOSIS OF ACUTE CORONARY SYNDROMES IN DIABETIC PATIENTS ZAID AMMOURI, ANASS MAAROUFI, BELKOUCHIA SAMI, MOUSSAID MERIEM, AROUS SALIM, MEG BENOUNA, ABDENASSER DRIGHIL, AZZOUZI LEILA, HABBAL RACHIDA MOROCCO Background: Diabetes mellitus (DM) is an increasingly widespread disease across the globe due to ageing and lifestyle, with numbers predicting a spread by up to 439 million by 2030. Diabetes mellitus is a threat to the healthcare system for its chronic course and the multitude of lethal complications across different organ systems. Acute coronary syndromes (ACS) are major cardiovascular adverse outcomes in patients with type 2 diabetic mellitus. We are going to study the prognosis and the outcomes of patients with DM suffering for an ACS. Our study was a retrospective, comparative, and analytical, which enrolled 766 patients with ACS admitted in IBN RICHD UNIVERSITARY Hospital’s Cardiac Intensive Care Unit in Casablanca, Morocco, from January 2019 to January 2022. Our study population was divided into two groups: group A with diabetic patients (defined by HbA1c > 6,4%) and group B with non-diabetic patients. Clinical and paraclinical profiles as well as outcomes of both groups were compared. 766 patients were included, 336 NTSEMI, 430 STEMI, among them 331 (43%) were diabetic. We found a male predominance in both groups but a less predominant male proportion in group A (51.3% vs. 78.4%; p = 0.003). More comorbidities such as arterial hypertension (61.8 vs. 32.9%; p < 0,001), dyslipidemia (49.3 vs. 18.3%; p = 0.003), and chronic kidney disease (16.5 vs. 3.5%; p = 0,021). More bad outcomes and complications were found in Group A patients overall, such as acute heart failure and RV or even Cardiogenic shock. Multivessel disease was more prevalent. Mortality was higher in diabetic patients DM group. Diabetes mellitus (DM) represents a major cardiovascular risk factor for increased risk of coronary artery disease and myocardial infarction (MI). DM is also associated with a poorer clinical outcome in MI. Submission ID: 1548 MOROCCANS’ MODIFIABLE RISK FACTORS OF SEVERE HEART FAILURE : A DESCRIPTIVE STUDY USING ROUTINELY COLLECTED HEALTH DATABASE HATIM HAJAR, EL MOUSAID MERIEM, CHARIF HANAA, ERRAMI AMINE, SEYDOU HAROUNA, BOUTALEB AMINE, HABOUB MERYEM, AZZOUZI LEILA, HABBAL RACHIDA MOROCCO Introduction: In Morocco, the prevalence of heart failure ( HF) is rising, and there is a startling lack of factors associated with severe heart failure (SHF) in this population.The purpose of this study was to identify modifiable risk factors of SHF in patients hospitalized for HF In Ibn Rochd Hospital ,Casablanca . Methods: A total of 105 patients were included in the analysis, for a median of 35 months between March 2018 and January 2022.To assess the severity of HF, New York Heart Association (NYHA) classification were applied. Patients with a NYHA class I or II were considered as having moderate HF (MHF), while those with a NYHA class III or IV were considered as having severe HF (SHF). Using logistic regression, we examined univariate and multivariate risk factors related to SHF. Following the pronouncement of the RECORD (Reporting of studies Conducted using Observational Routinelycollected Data) , the results were reported. Results: A total of 24 patients (33%) were determined to have FHS. In univariate analysis, four predictors of SHF were identified : hemoglobin <12 g/dL, neutrophil to lymphocyte ratio (NLR) >3, mean corpuscular hemoglobin concentration (MCHC) <32 picoliter, and high density lipoprotein (HDL) <0 .35 (mmol/L). Only NLR>3 and HDL <0.35 mmol/L remained independent predictors in multivariate analysis. Patients with NLR >3 had a 6-fold increased likelihood of SHF [adjusted odds ratio (AOR) : 6.78, 95% confidence interval (CI): 1.40-32.80, p=0.017] , and those with HDL <0.35 (mmol/L) had a 10-fold higher probability of SHF [AOR: 10.11, 95% CI: 2.26-45.27, p=0.002]. Conclusion: The ward clinicians in resource-constrained settings might employ the SHF-independent biomarkers identified in this study. to determine patients at high risk of developing cardiac complications. MODERATED POSTER SESSION
RkJQdWJsaXNoZXIy NDIzNzc=